[1] |
Bocchinfuso, W.P., Korach, K.S. Mammary gland development and tumorigenesis in estrogen receptor knockout mice J. Mammary Gland. Biol. Neoplasia, 2 (1997),pp. 323-334
|
[2] |
Cariou, S., Donovan, J.C., Flanagan, W.M. et al. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells Proc. Natl. Acad. Sci. U. S. A., 97 (2000),pp. 9042-9046
|
[3] |
Carroll, J.S., Liu, X.S., Brodsky, A.S. et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 Cell, 122 (2005),pp. 33-43
|
[4] |
Cauley, J.A., Lucas, F.L., Kuller, L.H. et al. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group Ann. Intern. Med., 130 (1999),pp. 270-277
|
[5] |
Chakravarty, D., Nair, S.S., Santhamma, B. et al. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells Cancer Res., 70 (2010),pp. 4092-4101
|
[6] |
Clarke, R.B. Ovarian steroids and the human breast: regulation of stem cells and cell proliferation Maturitas, 54 (2006),pp. 327-334
|
[7] |
Deroo, B.J., Korach, K.S. Estrogen receptors and human disease J. Clin. Investig., 116 (2006),pp. 561-570
|
[8] |
Frasor, J., Danes, J.M., Komm, B. et al. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype Endocrinology, 144 (2003),pp. 4562-4574
|
[9] |
Jeffy, B.D., Hockings, J.K., Kemp, M.Q. et al. An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription Neoplasia, 7 (2005),pp. 873-882
|
[10] |
Klinge, C.M. Estrogen receptor interaction with co-activators and co-repressors Steroids, 65 (2000),pp. 227-251
|
[11] |
Magnani, L., Ballantyne, E.B., Zhang, X. et al. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer PLoS Genet., 7 (2011),p. e1002368
|
[12] |
Russo, J., Russo, I.H. The role of estrogen in the initiation of breast cancer J. Steroid Biochem. Mol. Biol., 102 (2006),pp. 89-96
|
[13] |
Russo, J., Fernandez, S.V., Russo, P.A. et al. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells FASEB J., 20 (2006),pp. 1622-1634
|
[14] |
Shang, Y., Hu, X., DiRenzo, J. et al. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell, 103 (2000),pp. 843-852
|
[15] |
Stossi, F., Likhite, V.S., Katzenellenbogen, J.A. et al. J. Biol. Chem., 281 (2006),pp. 16272-16278
|
[16] |
Su, D., Fu, X., Fan, S. et al. Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells Am. J. Pathol., 180 (2012),pp. 1189-1201
|
[17] |
Warner, M., Nilsson, S., Gustafsson, J.A. The estrogen receptor family Curr. Opinion Obstet. Gynecol., 11 (1999),pp. 249-254
|
[18] |
Xu, J., Wu, R.C., O'Malley, B.W. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family Nat. Rev. Cancer, 9 (2009),pp. 615-630
|
[19] |
Yue, W., Yager, J.D., Wang, J.P. et al. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis Steroids, 78 (2013),pp. 161-170
|